Aging in cognitive control of social processing: evidence from the attention network test

ABSTRACT

Aging seems to be associated with impairment of attentional network functioning. It is not known whether social information can modulate this age-related decline. We used three variants of Attention Network test to examine the age-related decline of attentional effects in response to stimuli with and without social-cognitive content. Three groups of younger, middle-aged, and older participants performed the ANT, using fish, drawings, or photographs of faces looking to the left or right as target and flanker stimuli. The results showed that both executive attention and alerting were more resistant to the age-related decline with social stimuli and that orienting attention scores showed a progressive increase with age in the presence of this kind of stimuli. These findings underline the importance of social information in modulating and contrasting the age-related decline and support the status of human faces as a special class of visual stimuli for the human attentional systems.     

Global Diversification in Medicine Regulation: Insights from Regenerative Stem Cell Medicine

ABSTRACT

Medicine regulation worldwide has undergone a process of regulatory diversification. The evidence-based medicine (EBM) paradigm, centered on multi-phase randomized controlled trials, is increasingly contested and replaced by new models of clinical validation. To explain these changes, STS research has cited just a few factors, e.g. growing pressure form health consumers; the role of pharmaceutical companies to lobby for fast, affordable drug development; the influence of neoliberal ideas and libertarian advocacy of deregulation; and the agency of national governments to enable domestic innovation opportunities in the context of global competition and inequalities. Those factors individually cannot account for the increasing variation in medicine regulation at both national and global levels. Instead it is helpful to integrate elements of existing explanations into a framework with four pairs of conflicting regulatory choices, which play a central role in the formation of medicine regulation. We use this framework to compare regulatory changes in the USA, European Union, China, India, Argentina, and Japan. Across these jurisdictions, the case studies illustrate four dynamics of diversification. Key regulatory concepts such as evidence, risk, safety, efficacy, responsibility and accountability acquire different meanings, reshaping medicine innovation in far-reaching and often contradictory ways. The boundaries between medical research and healthcare provision, commerce and humanitarian service, as well as state control and medical self-regulation are re-defined.